Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

RSV and Rhinovirus asymptomatic upper airway infection increases pneumococcal carriage acquisition rates and density in adults whereas nasal inflammation is associated with bacterial shedding

Mitsi E. et al, (2024)

Experimental pneumococcal carriage in people living with HIV in Malawi: the first controlled human infection model in a key at-risk population

Doherty K. et al, (2024), Wellcome Open Research, 9, 2 - 2

Cellular and Transcriptional Signature of the Nasal Mucosa is Associated with Susceptibility to Pneumococcal Carriage in Older Adults

Urban BC. et al, (2023)

Combinatorial multimer staining and spectral flow cytometry facilitate quantification and characterization of polysaccharide-specific B cell immunity.

Hoving D. et al, (2023), Commun Biol, 6

Respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination.

Mitsi E. et al, (2023), Nat Commun, 14

Assessing the use of minimally invasive self-sampling at home for long-term monitoring of the microbiota within UK families.

Nikolaou E. et al, (2023), Sci Rep, 13

Effect of 13-valent pneumococcal conjugate vaccine on experimental carriage of Streptococcus pneumoniae serotype 6B in Blantyre, Malawi: a randomised controlled trial and controlled human infection study.

Dula D. et al, (2023), Lancet Microbe, 4, e683 - e691

A Randomised Controlled Trial of Nasal Immunisation with Live Virulence Attenuated Streptococcus pneumoniae Strains Using Human Infection Challenge.

Hill H. et al, (2023), Am J Respir Crit Care Med

Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.

Shaw RH. et al, (2023), J Infect, 86, 574 - 583

Surveillance towards preventing paediatric incidence of respiratory syncytial virus attributable respiratory tract infection in primary and secondary/tertiary healthcare settings in Merseyside, Cheshire and Bristol, UK.

Fyles F. et al, (2023), BMJ Open Respir Res, 10

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Mitsi E. et al, (2023)

Long-term respiratory mucosal immune memory to SARS-CoV-2 after infection and vaccination

Mitsi E. et al, (2023)

A feasibility study of controlled human infection with intradermal Bacillus Calmette–Guérin (BCG) injection: Pilot BCG controlled human infection model

Carter E. et al, (2023)

Baseline gene signatures of reactogenicity to Ebola vaccination: a machine learning approach across multiple cohorts

Gonzalez Dias Carvalho PC. et al, (2023), Frontiers in Immunology, 14

Comprehensive review of safety in Experimental Human Pneumococcal Challenge.

Robinson RE. et al, (2023), PLoS One, 18

Detection of SARS-CoV-2 infection by saliva and nasopharyngeal sampling in frontline healthcare workers: An observational cohort study.

Walker NF. et al, (2023), PLoS One, 18

Participant perceptions and experiences of a novel community-based respiratory longitudinal sampling method in Liverpool, UK: A mixed methods feasibility study.

German EL. et al, (2023), PLoS One, 18

Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi

Gordon S. et al, (2023)

Practical considerations for a TB controlled human infection model (TB-CHIM); the case for TB-CHIM in Africa, a systematic review of the literature and report of 2 workshop discussions in UK and Malawi.

Gordon SB. et al, (2023), Wellcome Open Res, 8

Human Infection Challenge with Serotype 3 Pneumococcus.

Robinson RE. et al, (2022), Am J Respir Crit Care Med, 206, 1379 - 1392

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?